HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Americas (WHO region)
Americas (WHO region): HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) was 52.0% in 2014. ▲ Rising
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Americas (WHO region), 2003–2014
Source: World Health Organization, Global Health Observatory.
Analysis
Americas (WHO region) recorded 52.0% for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in 2014.
Compared with earlier readings it is down 1.9% on the previous year and up 8.3% over ten years.
Over the whole period, hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Americas (WHO region) peaked at 74.0% in 2003 and was at its lowest, 13.0%, in 2006.
The long-run direction has been consistently rising across the 12 years of available data.
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Americas (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 74.0% | — |
| 2004 | 48.0% | -35.1% |
| 2005 | 22.0% | -54.2% |
| 2006 | 13.0% | -40.9% |
| 2007 | 25.0% | +92.3% |
| 2008 | 33.0% | +32.0% |
| 2009 | 36.0% | +9.1% |
| 2010 | 52.0% | +44.4% |
| 2011 | 41.0% | -21.2% |
| 2012 | 60.0% | +46.3% |
| 2013 | 53.0% | -11.7% |
| 2014 | 52.0% | -1.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 35.9% | 13.0% | 74.0% | 7 |
| 2010s | 51.6% | 41.0% | 60.0% | 5 |
More health data for Americas (WHO region)
- Measles - number of reported cases, gaps filled 12,380 (2025)
- Diphtheria - number of reported cases, gaps filled 72 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 23 (2025)
- Total tetanus - number of reported cases, gaps filled 385 (2025)
- Pertussis - number of reported cases, gaps filled 24,640 (2025)
- Number of under-five deaths, annual growth rate -2.83 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -3.22 % change on previous year (2024)
- Number of infant deaths, annual growth rate -2.68 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate 22.22 % change on previous year (2024)
- Pertussis - number of reported cases, annual growth rate -20.67 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Americas (WHO region)?
- Hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Americas (WHO region) was 52.0% in 2014, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Americas (WHO region)?
- The highest recorded value was 74.0% in 2003.
- What is the lowest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Americas (WHO region)?
- The lowest recorded value was 13.0% in 2006.
- How does Americas (WHO region) rank for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Americas (WHO region) ranks 10th out of 11 groups with data for 2014.
- Is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) rising or falling in Americas (WHO region)?
- Over the last ten years it is up 8.3%. The long-run trend across the full record is rising.
- Where does this Americas (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 12 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).